Biomaterials are crucial in cancer therapy as they can be designed to deliver drugs directly to the tumor site, minimizing side effects and improving efficacy. For instance, nanoparticles can be engineered to carry chemotherapeutic agents and release them in response to specific stimuli, such as pH changes or enzymes present in the tumor microenvironment.
